Literature DB >> 21851970

Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism.

Thomas M Berghaus1, Maria Barac, Wolfgang von Scheidt, Martin Schwaiblmair.   

Abstract

INTRODUCTION: Although recurrent venous thromboembolism is a known risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), the prevalence of CTEPH after recurrent pulmonary embolism (PE) is not clear.
MATERIALS AND METHODS: A cohort screening study was performed to clarify the prevalence of echocardiographic variables indicating pulmonary hypertension (PH) in patients after recurrent PE.
RESULTS: 43 survivors of recurrent PE could be enrolled. Echocardiography indicated likely PH in 7 patients. In 5 out of these 7 patients PH was likely and the left ventricular function was normal. Right heart catheterization and ventilation/perfusion lung scan were performed in these patients. CTEPH could be diagnosed in all 5 patients (11.6% of the total study population). No World Health Organisation functional class (WHO-FC) I patient was suspected to have CTEPH. CTEPH was significantly more often diagnosed in WHO-FC III than in WHO-FC II (33.3% versus 9.5%; p=0.024).
CONCLUSIONS: CTEPH was found to be a frequent sequela in patients with recurrent PE. The prevalence of CTEPH is dependent on the patient's functional class. Evaluation for PH might be useful in symptomatic patients after recurrent PE.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21851970     DOI: 10.1016/j.thromres.2011.07.045

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Authors:  F C Roller; S Kriechbaum; A Breithecker; C Liebetrau; M Haas; C Schneider; A Rolf; S Guth; E Mayer; C Hamm; G A Krombach; C B Wiedenroth
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

Review 2.  Chronic Thromboembolic Pulmonary Hypertension: the Bedside.

Authors:  Yuri Matusov; Inderjit Singh; Yen-Rei Yu; Hyung J Chun; Bradley A Maron; Victor F Tapson; Michael I Lewis; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

3.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

4.  Evaluation of the Incidence of Chronic Thromboembolic Pulmonary Hypertension 1 Year After First Episode of Acute Pulmonary Embolism: A Cohort Study.

Authors:  Farid Rashidi; Rezayat Parvizi; Eisa Bilejani; Babak Mahmoodian; Fatemeh Rahimi; Ata Koohi
Journal:  Lung       Date:  2020-01-02       Impact factor: 2.584

5.  Incidence and risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a systematic review and meta-analysis of cohort studies.

Authors:  Meng Zhang; Ning Wang; Zhenguo Zhai; Mingyuan Zhang; Rongrong Zhou; Yanyan Liu; Yuanhua Yang
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  Risk marker associations with venous thrombotic events: a cross-sectional analysis.

Authors:  Beatrice A Golomb; Virginia T Chan; Julie O Denenberg; Sabrina Koperski; Michael H Criqui
Journal:  BMJ Open       Date:  2014-03-21       Impact factor: 2.692

7.  Role of FoxO1 and apoptosis in pulmonary vascular remolding in a rat model of chronic thromboembolic pulmonary hypertension.

Authors:  Chaosheng Deng; Zhanghua Zhong; Dawen Wu; Yunfei Chen; Ningfang Lian; Haibo Ding; Qiaoxian Zhang; Qichang Lin; Shuang Wu
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

8.  Chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Marion Delcroix; Xavier Jais; Michael M Madani; Hiromi Matsubara; Eckhard Mayer; Takeshi Ogo; Victor F Tapson; Hossein-Ardeschir Ghofrani; David P Jenkins
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.